Takeda announces launch of Framework to help support patient access to life-extending combination treatments
February 25, 2025Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access
The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …
Recce Pharmaceuticals reports positive phase 2 data for skin infection drug
February 17, 2025Research and Development Recce, Skin, diabetes, skin, skin infections
Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment …
PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study
February 14, 2025Clinical Research Opthalmology, age-related macular degeneration, clinical trials
Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
Cardinal Health’s Kangaroo OMNI™ Enteral Feeding Pump to launch in new international markets in 2025
February 6, 2025Sales and Marketing Kangaroo, enteral, feeding pump
The next generation Kangaroo OMNI™ enteral feeding pump delivers nutrition and hydration from hospital to home. DUBLIN, Ireland, Feb.4, 2025 …
European Commission launches new Biotech and Biomanufacturing Hub
February 3, 2025Research and Development Biomanufacturing, Corporate, European Commission, Hub, european union
The European Commission has announced the opening of a new Biotech and Biomanufacturing Hub, supporting start-ups and small- to medium-sized …
FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors
February 3, 2025Business Services, Conferences Air France KLM Martinair Cargo ., Amsterdam Airport Schiphol, Corporate, DHL Global Forwarding, FlyPharma Conferences, logistics
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, …
Prenatal care could be revolutionised suggests studies from BrightHeart
January 31, 2025Research and Development AI, BrightHeart, FDA, Obstetrics & Gynaecology, prenatal, studies
Private medical device and artificial intelligence (AI)-led company, BrightHeart, has revealed two studies which show an improvement to pre-natal care …
CANDOR Bioscience acquired by Medix Biochemica
January 31, 2025Sales and Marketing CANDOR biosciences, Diagnostics, Medix biochemica, acquisition, in vitro diagnostics
CANDOR Biosciences, a supplier in immunoassay solutions, has been acquired by Medix Biochemica, a supplier of raw materials for in …
MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients
January 30, 2025Research and Development MHRA, Oncology, approvals, multiple myeloma, rare diseases
The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in combination to treat multiple myeloma …
Bayer UK Launches New CanesMeno® Educational Hub and Product Range to Transform Menopause Support
January 30, 2025Medical Communications
29 January 2025 – Reading, UK – Bayer Consumer Health is entering the menopause category for the first time in …
NICE issues positive final guidance for treatment of Duchenne Muscular Dystrophy from Santhera
January 29, 2025Sales and Marketing Duchenne Muscular Dystrophy, EC, EMA, FDA, Santhera Pharmaceuticals, positive
Santhera Pharmaceuticals has received positive final guidance from the National Institute for Care and Excellence (NICE) for AGAMREE (vamorolone) to …
Positive topline results announced in phase 2 Alcohol Use Disorder study
January 29, 2025Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results
Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …
Results from Novadip phase 1b/2a trial reveal 88% efficacy
January 28, 2025Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases
Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
Jérôme Berger announced as strategy and finance executive at Vect-Horus
January 28, 2025appointment, private biotechnology company
Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jérôme Berger to its board of …
Research collaboration announced between Oxford University and GSK
January 27, 2025Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development
The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …
Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery
January 23, 2025Paris, Pharmapack 2025, Winners, pharmaceutical packaging and drug delivery
Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy™ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock™ …
Combination first-in-line treatment approved for patients with non-small cell lung cancer
January 23, 2025Research and Development J&J Innovative Medicine, Oncology, approval, non-small cell lung cancer
Johnson & Johnson Innovative Medicine have announced that the European Commission (EC) has approved a marketing authorisation for the combination …
Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris
January 23, 2025Medical Communications, Public Relations Heart of Pharma, Paris, pharmapack
Six start-ups bestowed with new ‘heart of pharma’ commendation in recognition of innovations advancing drug delivery and packaging 22 January …
Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project
January 22, 2025Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project
Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark
January 21, 2025Sales and Marketing CSL, Denmark, genetic, haemophilia, treatment
21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B …
Latest content
FibroFind appoints Lee Borthwick as CEO
